Omalizumab in IgE-Mediated Food Allergy: A Systematic Review and Meta-Analysis

A growing number of studies have shown encouraging results with omalizumab (OMA) as monotherapy and as an adjunct to oral immunotherapy (OMA+OIT) in patients with single/multiple food allergies. To evaluate the efficacy and safety of OMA or OMA+OIT in patients with immunoglobulin E (IgE)-mediated fo...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	The journal of allergy and clinical immunology in practice (Cambridge, MA) Ročník 11; číslo 4; s. 1134
Hlavní autori:	Zuberbier, Torsten, Wood, Robert A, Bindslev-Jensen, Carsten, Fiocchi, Alessandro, Chinthrajah, R Sharon, Worm, Margitta, Deschildre, Antoine, Fernandez-Rivas, Montserrat, Santos, Alexandra F, Jaumont, Xavier, Tassinari, Paolo
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 01.04.2023
Predmet:	Administration, Oral Allergens Animals Desensitization, Immunologic - methods Food Hypersensitivity - drug therapy Humans Immunoglobulin E Milk Omalizumab - therapeutic use Quality of Life Desensitization Omalizumab IgE-mediated food allergy Food (allergen) tolerance Sustained unresponsiveness Oral immunotherapy Meta-analysis
ISSN:	2213-2201, 2213-2201
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!